Informatics approaches to assessing patient frailty in surgical care
评估外科护理中患者虚弱程度的信息学方法
基本信息
- 批准号:10652340
- 负责人:
- 金额:$ 58.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AbdomenAcuteAddressAgeAgingAlgorithmsAmericanBiologicalCaringChronic DiseaseChronologyClinicalCodeComplexComputer softwareConsumptionCounselingDataData SetDecision MakingDiagnosticElderlyElectronic Health RecordElectronicsExhibitsFutureGoalsHospital CostsHospital MortalityHospitalsInfiltrationInformaticsInterventionLaboratoriesLength of StayManualsMeasuresMethodologyModelingMorbidity - disease rateMuscleMuscular AtrophyNational Institute on AgingOperative Surgical ProceduresPathway interactionsPatient-Focused OutcomesPatientsPerformancePerioperativePerioperative CarePhysical FunctionPhysiologicalPopulationPopulation HeterogeneityPostoperative PeriodPredictive ValueProcessResearchRiskRisk FactorsScanningSeverity of illnessSkeletal MuscleStandardizationSurgical complicationTechnologyTimeValidationX-Ray Computed Tomographyadverse outcomeclinical carecomputer sciencecostdigitalelectronic datafrailtyfunctional statushigh riskhospital readmissionimprovedinnovationinpatient surgerymortalitymuscle formolder patientpatient responseperformance testspostoperative recoverypredictive modelingprofiles in patientsprogramsprospectiverisk stratificationsarcopeniasecondary analysisshared decision makingstressorsurgery outcomesurgical risktool
项目摘要
ABSTRACT
Surgical complications are common, costly, and deadly. Older patients are at high risk of adverse surgical
outcomes, especially when they exhibit frailty. Frailty is a state of decreased physiologic reserve and loss of
capacity to adapt to stressors. Over the past decade, while frailty has been increasingly recognized as an
important risk factor for poor surgical outcomes, integration of a standardized frailty metric into clinical care has
not been achieved. A key barrier is that existing frailty assessments are not standardized, objective, or widely
available, limiting their routine application in surgical decision-making. With the long-term goal of improving
surgical care for older adults, we will evaluate two “e-frailty” metrics that can be automatically derived from
electronic or digital data that are already collected as part of routine clinical care. These e-frailty metrics
include, first, granular patient profiles of electronic health record (EHR) data (risk scores based on claims data
or on physiologic and laboratory values), and second, muscle loss assessed from pre-surgical computed
tomography (CT) scans (low skeletal muscle mass, known as sarcopenia, and fatty infiltration into muscle
indicative of reduced physical function, known as myosteatosis). In Aim 1, we will calculate these two e-frailty
metrics among a diverse population of over 41,000 abdominal surgical patients; characterize the overlap
between patients designated as frail by the two e-frailty metrics; and evaluate their associations with 30-day
readmission and other adverse surgical outcomes (30-day and 1-year mortality, complications, non-home
discharge, and length of stay >7 days). In Aim 2, we will compare the performance of e-frailty metrics for
predicting 30-day readmission and other adverse surgical outcomes to that of standard risk stratification tools
(acute and chronic illness severity metrics) already embedded in EHRs today using cross-validation and an
independent validation dataset of over 14,000 more recent abdominal surgeries. In Aim 3, we will examine
whether e-frailty metrics modify the benefits that patients derive from achieving postoperative targets -including
early and sustained mobilization- in one of the largest Enhanced Recovery After Surgery (ERAS) programs in
the nation. We will examine e-frailty metrics as salient indicators of biologic age for predicting morbidity and
mortality. In sum, e-frailty metrics show great promise for identifying high-risk patients in the surgical domain,
but they need to be integrated within clinical workflows to be scalable and sustainable. This proposal will
compute standardized e-frailty metrics automatically derived from EHR data and provide new information
regarding the potential value of these e-frailty metrics for improving surgical care for older adults. This study
will also lay the groundwork for future prospective interventions integrating e-frailty metrics into clinical care to
improve risk stratification and counseling of patients considering surgery and enhance perioperative care for
frail surgical patients.
抽象的
手术并发症很常见,费用昂贵且致命。
尤其是当他们表现出虚弱时,虚弱是一种生理储备减少和丧失的状态。
在过去的十年中,人们越来越认识到虚弱是一种适应压力的能力。
手术结果不佳的重要风险因素,将标准化衰弱指标纳入临床护理已
尚未实现的一个主要障碍是现有的衰弱评估不够标准化、客观或广泛。
可用,限制了它们在手术决策中的常规应用。
对于老年人的手术护理,我们将评估两个“电子衰弱”指标,这些指标可以自动导出
这些电子衰弱指标已作为常规临床护理的一部分收集。
首先,包括电子健康记录 (EHR) 数据的详细患者档案(基于索赔数据的风险评分)
或根据生理和实验室值),第二,根据手术前计算得出的肌肉损失评估
断层扫描 (CT) 扫描(骨骼肌质量低,称为肌肉减少症,以及脂肪浸润肌肉
表明身体功能下降,称为肌脂肪变性)。在目标 1 中,我们将计算这两个 e-frailty。
超过 41,000 名腹部手术患者的不同人群的指标描述了重叠的特征;
在通过两个电子衰弱指标指定为衰弱的患者之间进行比较,并评估它们与 30 天的关联;
再入院和其他不良手术结果(30 天和 1 年死亡率、并发症、非家庭
在目标 2 中,我们将比较电子衰弱指标的表现。
根据标准风险分层工具预测 30 天再入院和其他不良手术结果
(急性和慢性疾病严重程度指标)现已通过交叉验证和
在目标 3 中,我们将检查 14,000 多个近期腹部手术的独立验证数据集。
电子衰弱指标是否会改变患者从实现术后目标中获得的益处,包括
早期和持续的活动——这是美国最大的加速康复外科 (ERAS) 计划之一
我们将研究电子衰弱指标作为预测发病率和生物年龄的显着指标。
总之,电子衰弱指标在识别外科领域的高危患者方面显示出巨大的前景。
但它们需要集成到临床工作流程中才能实现可扩展和可持续。
计算从 EHR 数据自动得出的标准化电子衰弱指标并提供新信息
关于这些电子衰弱指标对于改善老年人手术护理的潜在价值。
还将为未来将电子衰弱指标纳入临床护理的前瞻性干预措施奠定基础
改善考虑手术的患者的风险分层和咨询,并加强围手术期护理
体弱的手术患者。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Quantifying Frailty Requires a Conceptual Model Before a Statistical Model-Reply.
量化衰弱需要在统计模型回复之前建立概念模型。
- DOI:10.1001/jamasurg.2022.3113
- 发表时间:2022
- 期刊:
- 影响因子:16.9
- 作者:Le,SidneyT;Liu,VincentX;CespedesFeliciano,ElizabethM
- 通讯作者:CespedesFeliciano,ElizabethM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth Marjorie Cespedes Feliciano其他文献
Elizabeth Marjorie Cespedes Feliciano的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth Marjorie Cespedes Feliciano', 18)}}的其他基金
Understanding the role of adiposity and adipokine-related RNA expression in the tumor microenvironment on breast cancer outcomes in a racially and ethnically diverse sample
了解肿瘤微环境中肥胖和脂肪因子相关 RNA 表达对种族和民族多样化样本中乳腺癌结果的作用
- 批准号:
10602753 - 财政年份:2022
- 资助金额:
$ 58.85万 - 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物
- 批准号:
10029647 - 财政年份:2020
- 资助金额:
$ 58.85万 - 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物
- 批准号:
10198876 - 财政年份:2020
- 资助金额:
$ 58.85万 - 项目类别:
Informatics approaches to assessing patient frailty in surgical care
评估外科护理中患者虚弱程度的信息学方法
- 批准号:
10242206 - 财政年份:2020
- 资助金额:
$ 58.85万 - 项目类别:
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients
D3-肌酸稀释液测定结肠癌患者的骨骼肌质量
- 批准号:
10337029 - 财政年份:2020
- 资助金额:
$ 58.85万 - 项目类别:
Informatics approaches to assessing patient frailty in surgical care
评估外科护理中患者虚弱程度的信息学方法
- 批准号:
10407652 - 财政年份:2020
- 资助金额:
$ 58.85万 - 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物
- 批准号:
10425385 - 财政年份:2020
- 资助金额:
$ 58.85万 - 项目类别:
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients
D3-肌酸稀释液测定结肠癌患者的骨骼肌质量
- 批准号:
10579981 - 财政年份:2020
- 资助金额:
$ 58.85万 - 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors - Disparities Supplement
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物 - Disparities Supplement
- 批准号:
10712034 - 财政年份:2020
- 资助金额:
$ 58.85万 - 项目类别:
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors
身体成分和乳腺癌生存:乳腺肿瘤中的免疫和代谢生物标志物
- 批准号:
10665682 - 财政年份:2020
- 资助金额:
$ 58.85万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
A Novel Assay to Improve Translation in Analgesic Drug Development
改善镇痛药物开发转化的新方法
- 批准号:
10726834 - 财政年份:2023
- 资助金额:
$ 58.85万 - 项目类别:
MECHANISMS OF VISCERAL PAIN DRIVEN BY SMALL INTESTINAL MICROBIOTA
小肠微生物驱动内脏疼痛的机制
- 批准号:
10836298 - 财政年份:2023
- 资助金额:
$ 58.85万 - 项目类别:
Development of a Novel Animal Model for Spinal Cord Injury with Sepsis
脓毒症脊髓损伤新型动物模型的开发
- 批准号:
10665862 - 财政年份:2023
- 资助金额:
$ 58.85万 - 项目类别:
Integration of non-invasive deep tissue microwave thermometry in the VectRx hyperthermia device in a transgenic liver tumor pig model
在转基因肝肿瘤猪模型中将非侵入性深部组织微波测温技术集成到 VectRx 热疗装置中
- 批准号:
10697183 - 财政年份:2023
- 资助金额:
$ 58.85万 - 项目类别: